CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Consolidated net income	$ 2,147	$ 1,807
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation, depletion and amortization	1,615	1,545
Deferred income tax expense (benefit)	65	69
Interest accretion on landfill and environmental remediation liabilities	99	97
Provision for bad debts	37	36
Equity-based compensation expense	84	71
Net gain on disposal of assets	(72)	(33)
(Gain) loss from divestitures, asset impairments and other, net	62	(3)
Equity in net (income) losses of unconsolidated entities, net of dividends	(4)	41
Change in operating assets and liabilities, net of effects of acquisitions and divestitures:
Receivables	(230)	(197)
Other current assets	(38)	(26)
Other assets	93	67
Accounts payable and accrued liabilities	149	63
Deferred revenues and other liabilities	(128)	(200)
Net cash provided by operating activities	3,879	3,337
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(782)	(139)
Capital expenditures	(2,116)	(1,853)
Proceeds from divestitures of businesses and other assets, net of cash divested	99	68
Other, net	(40)	(83)
Net cash used in investing activities	(2,839)	(2,007)
Cash flows from financing activities:
New borrowings	10,914	17,319
Debt repayments	(10,619)	(16,991)
Common stock repurchase program	(262)	(990)
Cash dividends	(909)	(855)
Exercise of common stock options	42	29
Tax payments associated with equity-based compensation transactions	(49)	(28)
Other, net	(20)	(9)
Net cash used in financing activities	(903)	(1,525)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents	(2)
(Decrease) increase in cash, cash equivalents and restricted cash and cash equivalents	135	(195)
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period	552	445
Cash, cash equivalents and restricted cash and cash equivalents at end of period	$ 687	$ 250